Zhu et al., 2023 - Google Patents
FOXP2 confers oncogenic effects in prostate cancerZhu et al., 2023
View PDF- Document ID
- 11072884144778016386
- Author
- Zhu X
- Chen C
- Wei D
- Xu Y
- Liang S
- Jia W
- Li J
- Qu Y
- Zhai J
- Zhang Y
- Wu P
- Hao Q
- Zhang L
- Zhang W
- Yang X
- Pan L
- Qi R
- Li Y
- Wang F
- Yi R
- Yang Z
- Wang J
- Zhao Y
- Publication year
- Publication venue
- Elife
External Links
Snippet
Identification oncogenes is fundamental to revealing the molecular basis of cancer. Here, we found that FOXP2 is overexpressed in human prostate cancer cells and prostate tumors, but its expression is absent in normal prostate epithelial cells and low in benign prostatic …
- 101001059881 Homo sapiens Forkhead box protein P2 0 title abstract description 249
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stringer et al. | A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma | |
Yang et al. | Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway | |
Zingg et al. | Truncated FGFR2 is a clinically actionable oncogene in multiple cancers | |
Zhou et al. | TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer | |
Whissell et al. | The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression | |
Compagno et al. | Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells | |
Lin et al. | FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival | |
Veeraraghavan et al. | Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers | |
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project Wu Gang 1 Diaz Alexander K 2 3 Paugh Barbara S 2 Rankin Sherri L 2 Ju Bensheng 4 Li Yongjin 1 Zhu Xiaoyan 2 Qu Chunxu 1 Chen Xiang 1 Zhang Junyuan 2 Easton John 5 Edmonson Michael 1 Ma Xiaotu 1 Lu Charles 6 Nagahawatte Panduka 1 Hedlund Erin 1 Rusch Michael 1 Pounds Stanley 7 Lin Tong 7 Onar-Thomas Arzu 7 http://orcid. org/0000-0001-7077-7470 Huether Robert 1 Kriwacki Richard 8 Parker Matthew 1 Gupta Pankaj 1 Becksfort Jared 1 Wei Lei 9 Mulder Heather L 5 Boggs Kristy 5 Vadodaria Bhavin 5 Yergeau Donald 5 Russell Jake C 2 Ochoa Kerri 6 Fulton Robert S 6 Fulton Lucinda L 6 Jones Chris 10 11 Boop Frederick A 12 Broniscer Alberto 13 Wetmore Cynthia 13 Gajjar Amar 13 Ding Li 6 Mardis Elaine R 6 Wilson Richard K 6 Taylor Michael R 4 Downing James R 14 Ellison David W 14 Zhang Jinghui jinghui. zhang@ stjude. org 1 ba Baker Suzanne J suzanne. baker@ stjude. org 2 3 bb | The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma | |
Wu et al. | Identification of targetable FGFR gene fusions in diverse cancers | |
Robinson et al. | Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer | |
Zhang et al. | Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases | |
Rahrmann et al. | Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen | |
Wu et al. | Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer | |
Oh et al. | Alterations in the NF2/LATS1/LATS2/YAP pathway in schwannomas | |
Kim et al. | H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation | |
Zhong et al. | Circular RNA encoded MET variant promotes glioblastoma tumorigenesis | |
Guan et al. | FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer | |
Zhu et al. | FOXP2 confers oncogenic effects in prostate cancer | |
Zhu et al. | Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5 | |
Shi et al. | The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA | |
Gong et al. | Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis | |
Annala et al. | Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer | |
Hsieh et al. | Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors | |
Rebolledo-Jaramillo et al. | Teneurins: an integrative molecular, functional, and biomedical overview of their role in cancer |